Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Atossa Therapeutics's total assets was $32.28M at Jun 30, 2026. For fiscal 2025 it was $47.61M, down 37.7% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $141.26M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.61M | -37.7% |
| FY2024 | Dec 31, 2024 | $76.44M | -20.6% |
| FY2023 | Dec 31, 2023 | $96.25M | -22.1% |
| FY2022 | Dec 31, 2022 | $123.53M | -12.6% |
| FY2021 | Dec 31, 2021 | $141.26M | +229.8% |
| FY2020 | Dec 31, 2020 | $42.84M | +195.6% |
| FY2019 | Dec 31, 2019 | $14.49M | +23.6% |
| FY2018 | Dec 31, 2018 | $11.72M | +43.6% |
| FY2017 | Dec 31, 2017 | $8.16M | +97.0% |
| FY2016 | Dec 31, 2016 | $4.14M | -33.6% |
| FY2015 | Dec 31, 2015 | $6.24M | -46.9% |
| FY2014 | Dec 31, 2014 | $11.76M | -2.0% |
| FY2013 | Dec 31, 2013 | $12.01M | +75.9% |
| FY2012 | Dec 31, 2012 | $6.83M | +122.2% |
| FY2011 | Dec 31, 2011 | $3.07M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.28M | -50.0% |
| Q1 FY2026 | Mar 31, 2026 | $37.94M | -46.4% |
| Q4 FY2025 | Dec 31, 2025 | $47.61M | -37.7% |
| Q3 FY2025 | Sep 30, 2025 | $58.01M | -27.0% |
| Q2 FY2025 | Jun 30, 2025 | $64.52M | -24.9% |
| Q1 FY2025 | Mar 31, 2025 | $70.75M | -22.3% |
| Q4 FY2024 | Dec 31, 2024 | $76.44M | -20.6% |
| Q3 FY2024 | Sep 30, 2024 | $79.48M | -21.8% |
| Q2 FY2024 | Jun 30, 2024 | $85.86M | -20.8% |
| Q1 FY2024 | Mar 31, 2024 | $91.09M | -21.6% |
| Q4 FY2023 | Dec 31, 2023 | $96.25M | -22.1% |
| Q3 FY2023 | Sep 30, 2023 | $101.70M | -19.8% |
| Q2 FY2023 | Jun 30, 2023 | $108.36M | -19.2% |
| Q1 FY2023 | Mar 31, 2023 | $116.20M | -15.5% |
| Q4 FY2022 | Dec 31, 2022 | $123.53M | -12.6% |
| Q3 FY2022 | Sep 30, 2022 | $126.72M | -11.4% |
| Q2 FY2022 | Jun 30, 2022 | $134.05M | -8.1% |
| Q1 FY2022 | Mar 31, 2022 | $137.48M | -2.6% |
| Q4 FY2021 | Dec 31, 2021 | $141.26M | +229.8% |
| Q3 FY2021 | Sep 30, 2021 | $143.02M | +1150.5% |
| Q2 FY2021 | Jun 30, 2021 | $145.87M | +1329.3% |
| Q1 FY2021 | Mar 31, 2021 | $141.08M | +1094.4% |
| Q4 FY2020 | Dec 31, 2020 | $42.84M | +195.6% |
| Q3 FY2020 | Sep 30, 2020 | $11.44M | -31.1% |
| Q2 FY2020 | Jun 30, 2020 | $10.21M | -45.2% |
| Q1 FY2020 | Mar 31, 2020 | $11.81M | -43.8% |
| Q4 FY2019 | Dec 31, 2019 | $14.49M | +23.6% |
| Q3 FY2019 | Sep 30, 2019 | $16.60M | +17.5% |
| Q2 FY2019 | Jun 30, 2019 | $18.61M | +12.3% |
| Q1 FY2019 | Mar 31, 2019 | $21.02M | +251.6% |
| Q4 FY2018 | Dec 31, 2018 | $11.72M | +43.6% |
| Q3 FY2018 | Sep 30, 2018 | $14.12M | +288.6% |
| Q2 FY2018 | Jun 30, 2018 | $16.58M | +252.0% |
| Q1 FY2018 | Mar 31, 2018 | $5.98M | +159.7% |
| Q4 FY2017 | Dec 31, 2017 | $8.16M | +97.0% |
| Q3 FY2017 | Sep 30, 2017 | $3.63M | -42.1% |
| Q2 FY2017 | Jun 30, 2017 | $4.71M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.14M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.28M | – |
See a number that looks wrong?